Tectonic Therapeutic | AVRO - Market Capitalization


Tectonic Therapeutic reported $501.6M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 502M 75M Mar/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.57B 967M Sep/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 624.22M 38.25M Mar/2026
Laboratorios Farma EUR 4.16B 904.2M Mar/2026
MacroGenics USD 106M 29M Sep/2025
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 38.41M 24.12M Mar/2026
Neuren Pharmaceuticals AUD 1.71B 645.78M Mar/2026
Organigram Holdings CAD 378.8M 132.2M Sep/2025
Ovoca Bio EUR 7.54M 4.28M Jun/2022
Pfizer USD 141.57B 6.48B Dec/2025
Pharma Mar EUR 1.41B 63.87M Mar/2026
Qiagen NV USD 9.9B 207.4M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Sartorius EUR 16.41B 2.95B Dec/2025
Sino Biopharmaceutical CNY 114.44B 24.38B Mar/2026
Takeda JPY 7.64T 774.9B Dec/2025
Zealand Pharma A/S 33.35B 0 Feb/2026
Zz Pientze Pharmaceu CNY 118.73B 1.94B Sep/2025